The diagnosed incident cases of glioblastoma (GBM) in the eight major markets (8MM*) are set to increase at an annual growth rate (AGR) of 0.81% from over 61,000 in 2025 to over 66,000 in 2035, forecasts GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Glioblastoma (GBM): Epidemiology Report and Forecast[SP1] to 2035,” reveals […]